TN2 brings together fundamental and clinical researchers in the field of Translational Neuroscience from all over the Netherlands and beyond to Amsterdam.
TN2 conferences are being held as a satellite conference of the Annual Meeting of Amsterdam Neuroscience (VUmc and AMC). This conference is of interest to Translational Neuroscientists of all academic levels.
TN2 brings state-of-the-art Neuroscience on Alzheimer’s Disease, Dementia, Parkinson’s Disease, Meningitis and Multiple Sclerosis in the spotlight, but also provide excellent opportunities for academia and industrial partners to explore new collaborations potentially leading to translation of novel disease mechanisms into effective drug therapies and disease-monitoring diagnostic tools.
The scientific strategy in this field is often bidirectional in nature, encompassing both bench-to-bedside factors, which aim to increase the efficiency by which new therapeutic strategies developed through basic research are tested clinically, and bedside-to-bench factors, which provide feedback about the efficacy of the clinical application of new treatments and how they can be improved.